ALZAMEND NEURO, INC.

Consensus Alzamend Neuro, Inc.

Stocks

ALZN

US02262M6057

Biotechnology & Medical Research

Market Closed - Nasdaq 21:00:00 11/09/2026 BST			5-day change	1st Jan Change
1.720 ^USD	+1.18%		+3.61%	-5.49%

09-10	Alzamend Neuro, Inc. Reports Earnings Results for the First Quarter Ended July 31, 2026	CI
08-20	Alzamend Neuro Reports Resting-State Fmri Findings For Al001 Accepted For Poster Presentation At Neuroscience 2026	CI

Evolution of the Average Target: Alzamend Neuro, Inc.

Evolution of the Target Price: Alzamend Neuro, Inc.

Changes in Analyst Recommendations: Alzamend Neuro, Inc.

3db82cf77f229be.rrcY_B_T-L6by0ZVNebfYrBd0FMgkW8S15PebHchwPI.xO5etEy_tNfesQAUeK6mG9cFmiRH4SR_mtCNARBzoqPf-HyEd6ez09KvKQ~3871173b4125b27110f7188e7276e1ea

Analysts' recommendations: Alzamend Neuro, Inc.

12/04/23	Maxim Initiates Alzamend Neuro at Buy With $1.50 Price Target	MT
27/12/21	Ascendiant Capital Adjusts Price Target on Alzamend Neuro to $8.25 From $8, Maintains Buy Rating	MT
01/10/21	Alzamend Neuro : Ascendiant Capital Initiates Alzamend Neuro at Buy Rating With $8 Price Target	MT

More recommendations

Other Biotechnology & Medical Research

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ALZAMEND NEURO, INC.			-	-	+1,411.63%
	LONZA GROUP AG					+29.55%
	REVOLUTION MEDICINES, INC.					+23.28%
	IQVIA HOLDINGS INC.					+5.54%
	BEONE MEDICINES AG					+24.8%
	CELLTRION, INC.					+50.52%
	ASCENDIS PHARMA A/S					+19.38%
	MEDPACE HOLDINGS, INC.					-0.97%
	EUROFINS SCIENTIFIC SE					+2.18%
	CHARLES RIVER LABORATORIES INTERNATIONAL, INC.					+1.5%
	Average					+156.74%
	Weighted average by Cap.					+21.04%

See all sector performances

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

1

Last Close Price

1.720USD

Average target price

26.00USD

Spread / Average Target

+1,411.63%

High Price Target

26.00USD

Spread / Highest target

+1,411.63%

Low Price Target

26.00USD

Spread / Lowest Target

+1,411.63%

Analyst Consensus Detail

Consensus revision (last 18 months)

Stock Market
Stocks
ALZN Stock
Consensus Alzamend Neuro, Inc.

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!

SEIZE THE OFFER!

×